# Valsartan + Hydrochlorothiazide

## Co-Diovan 80/12.5mg

##### 

| 藥品代碼   | OCOD                                                                                                                                                                                                                                                                                                                                                                |
|:-----------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症     | 2nd-line therapy for HTN in patients whose BP is not adequately controlled by monotherapy.                                                                                                                                                                                                                                                                          |
| 用法用量   | 1-2 tab daily.                                                                                                                                                                                                                                                                                                                                                      |
| 肝功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                        |
| 腎功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                        |
| 禁忌       | Severe hepatic impairment， biliary cirrhosis & cholestasis. Anuria， severe renal impairment. Refractory hypokalemia， hyponatremia， hypercalcemia & symptomatic hyperuricemia. Pregnancy.                                                                                                                                                                        |
| 副作用     | Headache， dizziness， nasopharyngitis， fatigue， upper respiratory tract infection， cough， diarrhea， arthralgia， back pain. Cardiovascular: Hypotension Gastrointestinal: Diarrhea (3%) Neurologic: Dizziness (9%)， Headache (2%) Renal: Serum blood urea nitrogen raised (15% )， Serum creatinine raised (2% ) Respiratory: Cough (3%) Other: Fatigue (5%) |
| 孕期建議   | Human data suggest risk in 2nd and 3 rd trimesters                                                                                                                                                                                                                                                                                                                  |
| 哺乳期建議 | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                                                                                                                                                                                 |

